These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. Martino G; Poliani PL; Furlan R; Marconi P; Glorioso JC; Adorini L; Comi G J Neuroimmunol; 2000 Jul; 107(2):184-90. PubMed ID: 10854655 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system. Furlan R; Pluchino S; Martino G Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077 [TBL] [Abstract][Full Text] [Related]
6. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice. Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666 [TBL] [Abstract][Full Text] [Related]
7. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Poliani PL; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi PC; Rovaris M; Uccelli A; Glorioso JC; Penna G; Adorini L; Comi G; 't Hart B; Martino G Hum Gene Ther; 2001 May; 12(8):905-20. PubMed ID: 11387056 [TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested. Castañeda-Lopez ME; Garza-Veloz I; Lopez-Hernandez Y; Barbosa-Cisneros OY; Martinez-Fierro ML Immunol Invest; 2016 Jul; 45(5):450-70. PubMed ID: 27245510 [TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
17. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404 [TBL] [Abstract][Full Text] [Related]
18. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077 [TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors. Piccirillo CA; Prud'homme GJ Hum Gene Ther; 1999 Aug; 10(12):1915-22. PubMed ID: 10466625 [TBL] [Abstract][Full Text] [Related]
20. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Skundric DS; Huston K; Shaw M; Tse HY; Raine CS Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]